Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma

BACKGROUND: In clear cell renal cell carcinoma (ccRCC), only some patients can benefit from immunotherapy therapy, and it is urgent to find immune-related molecular markers and targets. METHODS: Thymidine phosphorylase (TYMP) expression level and predictive value in pan-cancers were analyzed using T...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shao-An, Zhang, Jun-Peng, Wang, Ning, Chen, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695089/
https://www.ncbi.nlm.nih.gov/pubmed/38043946
http://dx.doi.org/10.1177/15330338231194555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695089/
https://www.ncbi.nlm.nih.gov/pubmed/38043946
http://dx.doi.org/10.1177/15330338231194555

Ejemplares similares